HSCSW(HSCSW)
HSCSW
No analyst ratings available
No analyst price targets available for HSCSW
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $700,000 | $3M |
| Low | $700,000 | $3M |
| High | $700,000 | $3M |
| EBITDA Avg | $-700,000 | $-3M |
| Low | $-700,000 | $-3M |
| High | $-700,000 | $-3M |
| EBIT Avg | $-700,000 | $-3M |
| Low | $-700,000 | $-3M |
| High | $-700,000 | $-3M |
| Net Income Avg | $-7M | $-5M |
| Low | $-7M | $-5M |
| High | $-7M | $-5M |
| EPS Avg | $-2.62 | $-1.86 |
| Low | $-2.62 | $-1.86 |
| High | $-2.62 | $-1.86 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |
| Metric | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|
| Revenue Avg | $100,000 | $200,000 | $300,000 | $100,000 | $100,000 | $1M | $2M |
| Low | $100,000 | $200,000 | $300,000 | $100,000 | $100,000 | $1M | $2M |
| High | $100,000 | $200,000 | $300,000 | $100,000 | $100,000 | $1M | $2M |
| EBITDA Avg | $-100,000 | $-200,000 | $-300,000 | $-100,000 | $-100,000 | $-1M | $-2M |
| Low | $-100,000 | $-200,000 | $-300,000 | $-100,000 | $-100,000 | $-1M | $-2M |
| High | $-100,000 | $-200,000 | $-300,000 | $-100,000 | $-100,000 | $-1M | $-2M |
| EBIT Avg | $-100,000 | $-200,000 | $-300,000 | $-100,000 | $-100,000 | $-1M | $-2M |
| Low | $-100,000 | $-200,000 | $-300,000 | $-100,000 | $-100,000 | $-1M | $-2M |
| High | $-100,000 | $-200,000 | $-300,000 | $-100,000 | $-100,000 | $-1M | $-2M |
| Net Income Avg | $-2M | $-2M | $-2M | $-2M | $-2M | $-1M | $-860,862 |
| Low | $-2M | $-2M | $-2M | $-2M | $-2M | $-1M | $-860,862 |
| High | $-2M | $-2M | $-2M | $-2M | $-2M | $-1M | $-860,862 |
| EPS Avg | $-0.65 | $-0.66 | $-0.59 | $-0.61 | $-0.57 | $-0.41 | $-0.27 |
| Low | $-0.65 | $-0.66 | $-0.59 | $-0.61 | $-0.57 | $-0.41 | $-0.27 |
| High | $-0.65 | $-0.66 | $-0.59 | $-0.61 | $-0.57 | $-0.41 | $-0.27 |
| Analysts (Rev / EPS) | 2 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |